Jasper Therapeutics
JSPR
JSPR
59 hedge funds and large institutions have $47.8M invested in Jasper Therapeutics in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
21% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 19
31% less capital invested
Capital invested by funds: $69.5M → $47.8M (-$21.6M)
Holders
59
Holding in Top 10
4
Calls
$315K
Puts
$125K
Top Buyers
| 1 | +$3.29M | |
| 2 | +$2.87M | |
| 3 | +$2.47M | |
| 4 |
PBM
Propel Bio Management
Los Angeles,
California
|
+$2.45M |
| 5 |
KCM
Kingdon Capital Management
New York
|
+$1.52M |
Top Sellers
| 1 | -$3.27M | |
| 2 | -$2.97M | |
| 3 | -$897K | |
| 4 |
Jane Street
New York
|
-$738K |
| 5 |
Goldman Sachs
New York
|
-$531K |